In sum, our data provide preclinical evidence that breast cancer can be prevented by short-term inhibition of TGFβ signaling that induces lasting changes in the mammary epithelium and identifies markers for future translational studies aimed at risk prediction and prevention in women with a high risk of breast cancer. The gene discussed is TGFB1; the disease is breast carcinoma.